Home/Filings/4/0001415889-25-003293
4//SEC Filing

Young James Emmett 4

Accession 0001415889-25-003293

CIK 0001826667other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 6:09 PM ET

Size

5.5 KB

Accession

0001415889-25-003293

Insider Transaction Report

Form 4
Period: 2025-02-05
Young James Emmett
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-02-05$5.65/sh+6,000$33,90030,000 total(indirect: By Trust)
Holdings
  • Common Stock

    21,726
Footnotes (1)
  • [F1]The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.

Issuer

TriSalus Life Sciences, Inc.

CIK 0001826667

Entity typeother

Related Parties

1
  • filerCIK 0002050748

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:09 PM ET
Size
5.5 KB